Keywords
Last Name
Institution

DAVID G POPLACK

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
DivisionPediatrics-Hematology & Oncology
AddressDepartment of Pediatrics - Hem/Onc
1102 Bates St., D1570
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gramatges MM, Bonaduce de Nigris F, King J, Horowitz ME, Fordis M, Poplack DG. Improving Childhood Cancer Survivor Care Through Web-Based Platforms. Oncology (Williston Park). 2018 01 15; 32(1):e1-e10. PMID: 29447422.
      View in: PubMed
    2. Poplack DG, Fordis M, Landier W, Bhatia S, Hudson MM, Horowitz ME. Childhood cancer survivor care: development of the Passport for Care. Nat Rev Clin Oncol. 2014 Dec; 11(12):740-50. PMID: 25348788.
      View in: PubMed
    3. Slone JS, Agrawal AK, Mehta PS, Mazhani L, Motumise K, Anabwani G, Poplack DG. Reply to "childhood cancer in Africa". Pediatr Blood Cancer. 2014 Aug; 61(8):1524. PMID: 24519963.
      View in: PubMed
    4. Marsland T, Arena F, Yeilding A, Glodé M, Ellis L, Yu J, Henderson C, Wagman L, Piver S, Minsky B, Rosen S, Poplack D, Potters L, Crawford D, Hoskins W. Perspective on...the new PSA screening recommendations. Oncology (Williston Park). 2011 Nov 15; 25(12):1183, 1187-8, 1190. PMID: 22229211.
      View in: PubMed
    5. Rabin KR, Poplack DG. Management strategies in acute lymphoblastic leukemia. Oncology (Williston Park). 2011 Apr 15; 25(4):328-35. PMID: 21618954.
      View in: PubMed
    6. Frugé E, Lakoski JM, Luban N, Lipton JM, Poplack DG, Hagey A, Felgenhauer J, Hilden J, Margolin J, Vaiselbuh SR, Sakamoto KM. Increasing diversity in pediatric hematology/oncology. Pediatr Blood Cancer. 2011 Jul 15; 57(1):147-52. PMID: 21284078; PMCID: PMC3092025.
    7. Frugé E, Mahoney DH, Poplack DG, Horowitz ME. Leadership: "They never taught me this in medical school". J Pediatr Hematol Oncol. 2010 May; 32(4):304-8. PMID: 20445418.
      View in: PubMed
    8. Horowitz ME, Fordis M, Krause S, McKellar J, Poplack DG. Passport for care: implementing the survivorship care plan. J Oncol Pract. 2009 May; 5(3):110-2. PMID: 20856747; PMCID: PMC2790686.
    9. Nathan PC, Whitcomb T, Wolters PL, Steinberg SM, Balis FM, Brouwers P, Hunsberger S, Feusner J, Sather H, Miser J, Odom LF, Poplack D, Reaman G, Bleyer WA. Very high-dose methotrexate (33.6 g/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma. 2006 Dec; 47(12):2488-504. PMID: 17169794.
      View in: PubMed
    10. Poplack DG. Introduction: pediatric oncology. Cancer J. 2005 Jul-Aug; 11(4):253-4. PMID: 16197715.
      View in: PubMed
    11. Blaney SM, Balis FM, Berg S, Arndt CA, Heideman R, Geyer JR, Packer R, Adamson PC, Jaeckle K, Klenke R, Aikin A, Murphy R, McCully C, Poplack DG. Intrathecal mafosfamide: a preclinical pharmacology and phase I trial. J Clin Oncol. 2005 Mar 1; 23(7):1555-63. PMID: 15735131.
      View in: PubMed
    12. Widemann BC, Balis FM, Shalabi A, Boron M, O'Brien M, Cole DE, Jayaprakash N, Ivy P, Castle V, Muraszko K, Moertel CL, Trueworthy R, Hermann RC, Moussa A, Hinton S, Reaman G, Poplack D, Adamson PC. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst. 2004 Oct 20; 96(20):1557-9. PMID: 15494606.
      View in: PubMed
    13. Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG, Balis FM. Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol. 2003 Jan 1; 21(1):143-7. PMID: 12506183.
      View in: PubMed
    14. Blaney SM, Poplack DG. Neoplastic meningitis: diagnosis and treatment considerations. Med Oncol. 2000 Aug; 17(3):151-62. PMID: 10962524.
      View in: PubMed
    15. Balis FM, Blaney SM, McCully CL, Bacher JD, Murphy RF, Poplack DG. Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol. 2000; 45(3):259-64. PMID: 10663645.
      View in: PubMed
    16. Roth JS, McCully CM, Balis FM, Poplack DG, Kelley JA. 2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition. Drug Metab Dispos. 1999 Oct; 27(10):1128-32. PMID: 10497138.
      View in: PubMed
    17. Hurwitz RL, Brenner MK, Poplack DG, Horowitz MC. Retinoblastoma treatment. Science. 1999 Jul 30; 285(5428):663-4. PMID: 10454919.
      View in: PubMed
    18. Moser AM, Adamson PC, Gillespie AJ, Poplack DG, Balis FM. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Cancer. 1999 Jan 15; 85(2):511-6. PMID: 10023723.
      View in: PubMed
    19. Berg SL, Reid J, Godwin K, Murry DJ, Poplack DG, Balis FM, Ames MM. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model. J Pediatr Hematol Oncol. 1999 Jan-Feb; 21(1):26-30. PMID: 10029808.
      View in: PubMed
    20. Balis FM, Holcenberg JS, Poplack DG, Ge J, Sather HN, Murphy RF, Ames MM, Waskerwitz MJ, Tubergen DG, Zimm S, Gilchrist GS, Bleyer WA. Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Blood. 1998 Nov 15; 92(10):3569-77. PMID: 9808549.
      View in: PubMed
    21. Blaney SM, Poplack DG. New cytotoxic drugs for intrathecal administration. J Neurooncol. 1998 Jun-Jul; 38(2-3):219-23. PMID: 9696375.
      View in: PubMed
    22. Murray JC, Poplack DG, Mahoney DH, Gresik MV, Harrison WR, Cooley LD. Detection of double minute chromosomes in a child with acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1998 Mar; 101(2):138-42. PMID: 9494616.
      View in: PubMed
    23. Blaney SM, Needle MN, Gillespie A, Sato JK, Reaman GH, Berg SL, Adamson PC, Krailo MD, Bleyer WA, Poplack DG, Balis FM. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clin Cancer Res. 1998 Feb; 4(2):357-60. PMID: 9516923.
      View in: PubMed
    24. Murry DJ, Riva L, Poplack DG. Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl. 1998; 11:48-51. PMID: 9876478.
      View in: PubMed
    25. Berg SL, Blaney SM, Adamson PC, O'Brien M, Poplack DG, Arndt C, Blatt J, Balis FM. Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers. J Clin Oncol. 1998 Jan; 16(1):181-6. PMID: 9440741.
      View in: PubMed
    26. Kitchen BJ, Balis FM, Poplack DG, O'Brien M, Craig CE, Adamson PC. A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion. Clin Cancer Res. 1997 May; 3(5):713-7. PMID: 9815740.
      View in: PubMed
    27. Blaney SM, Seibel NL, O'Brien M, Reaman GH, Berg SL, Adamson PC, Poplack DG, Krailo MD, Mosher R, Balis FM. Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial. J Clin Oncol. 1997 Apr; 15(4):1538-43. PMID: 9193350.
      View in: PubMed
    28. Blaney SM, Phillips PC, Packer RJ, Heideman RL, Berg SL, Adamson PC, Allen JC, Sallan SE, Jakacki RI, Lange BJ, Reaman GH, Horowitz ME, Poplack DG, Balis FM. Phase II evaluation of topotecan for pediatric central nervous system tumors. Cancer. 1996 Aug 1; 78(3):527-31. PMID: 8697400.
      View in: PubMed
    29. Fisherman JS, Cowan KH, Noone M, Denicoff A, Berg S, Poplack D, Balis F, Venzon D, McCabe M, Goldspiel B, Chow C, Ognibene FP, O'Shaughnessy J. Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. J Clin Oncol. 1996 Mar; 14(3):774-82. PMID: 8622023.
      View in: PubMed
    30. Wexler LH, Andrich MP, Venzon D, Berg SL, Weaver-McClure L, Chen CC, Dilsizian V, Avila N, Jarosinski P, Balis FM, Poplack DG, Horowitz ME. Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72. PMID: 8636745.
      View in: PubMed
    31. Geyer JR, Balis FM, Krailo MD, Heideman R, Broxson E, Sato JK, Poplack D, Bleyer WA. A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study. Invest New Drugs. 1996; 13(4):337-42. PMID: 8824353.
      View in: PubMed
    32. Berg SL, Poplack DG. Treatment of Meningeal Malignancy. Oncologist. 1996; 1(1 & 2):56-61. PMID: 10387969.
      View in: PubMed
    33. Blaney SM, Poplack DG. Pharmacologic strategies for the treatment of meningeal malignancy. Invest New Drugs. 1996; 14(1):69-85. PMID: 8880395.
      View in: PubMed
    34. Blaney SM, Poplack DG. Central nervous system leukemia. Curr Opin Oncol. 1996 Jan; 8(1):13-9. PMID: 8868094.
      View in: PubMed
    35. Felix CA, Wasserman R, Cesano A, Nowell PC, Hosler MR, Masterson M, Poplack DG, Santoli D. Clonal expansion of germline B-lineage acute lymphoblastic leukemia in severe combined immunodeficient mice. Oncogene. 1995 Nov 2; 11(9):1753-9. PMID: 7478603.
      View in: PubMed
    36. Adamson PC, Balis FM, Belasco JE, Lange B, Berg SL, Blaney SM, Craig C, Poplack DG. A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. Cancer Res. 1995 Sep 15; 55(18):4069-72. PMID: 7664282.
      View in: PubMed
    37. Berg SL, Poplack DG. Advances in the treatment of meningeal cancers. Crit Rev Oncol Hematol. 1995 Aug; 20(1-2):87-98. PMID: 7576199.
      View in: PubMed
    38. Hawkins ME, Mitsuya H, McCully CM, Godwin KS, Murakami K, Poplack DG, Balis FM. Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeys. Antimicrob Agents Chemother. 1995 Jun; 39(6):1259-64. PMID: 7574512; PMCID: PMC162723.
    39. Goorin A, Strother D, Poplack D, Letvak LA, George M, Link M. Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma. Med Pediatr Oncol. 1995 Jun; 24(6):362-7. PMID: 7715542.
      View in: PubMed
    40. Adamson PC, Bailey J, Pluda J, Poplack DG, Bauza S, Murphy RF, Yarchoan R, Balis FM. Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. J Clin Oncol. 1995 May; 13(5):1238-41. PMID: 7738627.
      View in: PubMed
    41. Moscow JA, Johnston PG, Cole D, Poplack DG, Cowan KH. Characterization of cross-resistance to methotrexate in a human breast cancer cell line selected for resistance to melphalan. Biochem Pharmacol. 1995 Apr 18; 49(8):1069-78. PMID: 7748187.
      View in: PubMed
    42. Blaney SM, Cole DE, Godwin K, Sung C, Poplack DG, Balis FM. Intrathecal administration of topotecan in nonhuman primates. Cancer Chemother Pharmacol. 1995; 36(2):121-4. PMID: 7767947.
      View in: PubMed
    43. Blaney SM, Poplack DG, Godwin K, McCully CL, Murphy R, Balis FM. Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration. J Clin Oncol. 1995 Jan; 13(1):177-9. PMID: 7799017.
      View in: PubMed
    44. Adamson PC, Poplack DG, Balis FM. The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leuk Res. 1994 Nov; 18(11):805-10. PMID: 7967706.
      View in: PubMed
    45. Felix CA, Wasserman R, Lange BJ, Brown DL, Nau MM, Cole DE, Minna JD, Poplack DG. Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutations. Leukemia. 1994 Jun; 8(6):963-7. PMID: 8207991.
      View in: PubMed
    46. Berg SL, Cowan KH, Balis FM, Fisherman JS, Denicoff AM, Hillig M, Poplack DG, O'Shaughnessy JA. Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion. J Natl Cancer Inst. 1994 Jan 19; 86(2):143-5. PMID: 7903702.
      View in: PubMed
    47. Brouwers P, Heyes MP, Moss HA, Wolters PL, Poplack DG, Markey SP, Pizzo PA. Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis. 1993 Dec; 168(6):1380-6. PMID: 8245522.
      View in: PubMed
    48. Adamson PC, Balis FM, Hawkins ME, Murphy RF, Poplack DG. Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells. Biochem Pharmacol. 1993 Nov 2; 46(9):1627-36. PMID: 8240420.
      View in: PubMed
    49. Berg SL, Balis FM, Godwin KS, Poplack DG. Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the rhesus monkey. Invest New Drugs. 1993 Nov; 11(4):255-61. PMID: 8157468.
      View in: PubMed
    50. Savarese DM, Denicoff AM, Berg SL, Hillig M, Baker SP, O'Shaughnessy JA, Chow C, Otterson GA, Balis FM, Poplack DG, et al. Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor. J Clin Oncol. 1993 Sep; 11(9):1795-803. PMID: 7689093.
      View in: PubMed
    51. Adamson PC, Pitot HC, Balis FM, Rubin J, Murphy RF, Poplack DG. Variability in the oral bioavailability of all-trans-retinoic acid. J Natl Cancer Inst. 1993 Jun 16; 85(12):993-6. PMID: 8388479.
      View in: PubMed
    52. Berg SL, Savarese DM, Balis FM, Denicoff AM, Hillig M, O'Shaughnessy JA, Poplack DG, Cowan KH. Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor. Cancer Res. 1993 Jun 1; 53(11):2587-90. PMID: 7684320.
      View in: PubMed
    53. Heideman RL, McCully C, Balis FM, Poplack DG. Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate. Invest New Drugs. 1993 May-Aug; 11(2-3):135-40. PMID: 7505267.
      View in: PubMed
    54. Blaney SM, Grem JL, Balis FM, Cole DE, Adamson PC, Poplack DG. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts. Biochem Pharmacol. 1993 Apr 6; 45(7):1493-501. PMID: 8471071.
      View in: PubMed
    55. Kim S, Khatibi S, Howell SB, McCully C, Balis FM, Poplack DG. Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoam. Cancer Res. 1993 Apr 1; 53(7):1596-8. PMID: 8453629.
      View in: PubMed
    56. Blaney SM, Balis FM, Cole DE, Craig C, Reid JM, Ames MM, Krailo M, Reaman G, Hammond D, Poplack DG. Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res. 1993 Mar 1; 53(5):1032-6. PMID: 8439950.
      View in: PubMed
    57. Blaney SM, Cole DE, Balis FM, Godwin K, Poplack DG. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res. 1993 Feb 15; 53(4):725-7. PMID: 8428353.
      View in: PubMed
    58. Adamson PC, Boylan JF, Balis FM, Murphy RF, Godwin KA, Gudas LJ, Poplack DG. Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. Cancer Res. 1993 Feb 1; 53(3):472-6. PMID: 8381046.
      View in: PubMed
    59. Berg SL, Balis FM, McCully CL, Godwin KS, Poplack DG. Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey. Cancer Chemother Pharmacol. 1993; 32(4):310-4. PMID: 8324873.
      View in: PubMed
    60. Adamson PC, Balis FM, Smith MA, Murphy RF, Godwin KA, Poplack DG. Dose-dependent pharmacokinetics of all-trans-retinoic acid. J Natl Cancer Inst. 1992 Sep 2; 84(17):1332-5. PMID: 1495103.
      View in: PubMed
    61. Adamson PC, Balis FM, McCully CL, Godwin KS, Poplack DG. Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys. J Clin Oncol. 1992 Aug; 10(8):1359-64. PMID: 1634927.
      View in: PubMed
    62. Blaney SM, Balis FM, Grem J, Cole DE, Adamson PC, Poplack DG. Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine. Cancer Res. 1992 Jun 15; 52(12):3503-5. PMID: 1596909.
      View in: PubMed
    63. Bogner MP, Voss SD, Bechhofer R, Hank JA, Roper M, Poplack D, Hammond D, Sondel PM. Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. J Immunother (1991). 1992 Feb; 11(2):111-8. PMID: 1571333.
      View in: PubMed
    64. Felix CA, Nau MM, Takahashi T, Mitsudomi T, Chiba I, Poplack DG, Reaman GH, Cole DE, Letterio JJ, Whang-Peng J, et al. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest. 1992 Feb; 89(2):640-7. PMID: 1737852; PMCID: PMC442897.
    65. Adamson PC, Balis FM, Miser J, Arndt C, Wells RJ, Gillespie A, Aronson L, Penta JS, Clendeninn NJ, Poplack DG. Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. Cancer Res. 1992 Feb 1; 52(3):521-4. PMID: 1732038.
      View in: PubMed
    66. Berg SL, Balis FM, McCully CL, Parker GA, Murphy RF, Poplack DG. Intrathecal 5-fluorouracil in the rhesus monkey. Cancer Chemother Pharmacol. 1992; 31(2):127-30. PMID: 1451233.
      View in: PubMed
    67. Adamson PC, Zimm S, Ragab AH, Balis F, Steinberg SM, Kamen BA, Vietti TJ, Gillespie A, Poplack DG. A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia. Cancer Chemother Pharmacol. 1992; 30(2):155-7. PMID: 1600597.
      View in: PubMed
    68. Felix CA, Poplack DG. Characterization of acute lymphoblastic leukemia of childhood by immunoglobulin and T-cell receptor gene patterns. Leukemia. 1991 Dec; 5(12):1015-25. PMID: 1837810.
      View in: PubMed
    69. Adamson PC, Balis FM, Arndt CA, Holcenberg JS, Narang PK, Murphy RF, Gillespie AJ, Poplack DG. Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. Cancer Res. 1991 Nov 15; 51(22):6079-83. PMID: 1933871.
      View in: PubMed
    70. Balis FM, Blaney SM, Poplack DG. Antiretroviral drug development and clinical pharmacology. Pediatr Infect Dis J. 1991 Nov; 10(11):849-57. PMID: 1661004.
      View in: PubMed
    71. Berg SL, Balis FM, McCully CL, Godwin KS, Poplack DG. Pharmacokinetics of pyrazoloacridine in the rhesus monkey. Cancer Res. 1991 Oct 15; 51(20):5467-70. PMID: 1913666.
      View in: PubMed
    72. O'Dwyer PJ, LaCreta F, Engstrom PF, Peter R, Tartaglia L, Cole D, Litwin S, DeVito J, Poplack D, DeLap RJ, et al. Phase I/pharmacokinetic reevaluation of thioTEPA. Cancer Res. 1991 Jun 15; 51(12):3171-6. PMID: 1710167.
      View in: PubMed
    73. Blaney SM, Balis FM, Poplack DG. Pharmacologic approaches to the treatment of meningeal malignancy. Oncology (Williston Park). 1991 May; 5(5):107-16; discussion 123, 127. PMID: 1831994.
      View in: PubMed
    74. Blaney SM, Balis FM, Poplack DG. Current pharmacological treatment approaches to central nervous system leukaemia. Drugs. 1991 May; 41(5):702-16. PMID: 1712705.
      View in: PubMed
    75. Horowitz ME, Poplack DG. Development of chemotherapy treatment for pediatric brain tumors. Neurol Clin. 1991 May; 9(2):363-73. PMID: 1944105.
      View in: PubMed
    76. Berg SL, Poplack DG. Complications of leukemia. Pediatr Rev. 1991 Apr; 12(10):313-8. PMID: 2017403.
      View in: PubMed
    77. Adamson PC, Balis FM, McCully CL, Godwin KS, Bacher JD, Walsh TJ, Poplack DG. Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2. J Clin Oncol. 1991 Apr; 9(4):670-4. PMID: 2066764.
      View in: PubMed
    78. Taubenberger JK, Cole DE, Raffeld M, Poplack DG, Jaffe ES, Medeiros LJ. Immunophenotypic analysis of acute lymphoblastic leukemia using routinely processed bone marrow specimens. Arch Pathol Lab Med. 1991 Apr; 115(4):338-42. PMID: 2012494.
      View in: PubMed
    79. Pasqualini T, McCalla J, Berg S, Poplack DG, Rose SR, Nisula BC, Cassorla F. Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia. Acta Endocrinol (Copenh). 1991 Apr; 124(4):375-80. PMID: 1903235.
      View in: PubMed
    80. Adamson PC, Horowitz ME, Poplack DG. The child with recurrent solid tumor. Pediatr Clin North Am. 1991 Apr; 38(2):489-504. PMID: 2006087.
      View in: PubMed
    81. Blaney SM, Balis FM, Hegedus L, Heideman RL, McCully C, Murphy RF, Kelley JA, Poplack DG. Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates. Cancer Res. 1990 Dec 15; 50(24):7915-9. PMID: 2253232.
      View in: PubMed
    82. Brouwers P, Moss H, Wolters P, Eddy J, Balis F, Poplack DG, Pizzo PA. Effect of continuous-infusion zidovudine therapy on neuropsychologic functioning in children with symptomatic human immunodeficiency virus infection. J Pediatr. 1990 Dec; 117(6):980-5. PMID: 2246704.
      View in: PubMed
    83. Adamson PC, Balis FM, Steinberg SM, Poplack DG, Holcenberg JS. Pharmacokinetics of mercaptopurine in children with acute lymphocytic leukemia. N Engl J Med. 1990 Nov 29; 323(22):1565-6. PMID: 2233941.
      View in: PubMed
    84. Hawkins ME, Poplack DG, Pizzo PA, Balis FM. High-performance liquid chromatographic method for the analysis of 2',3'-dideoxycytidine in human plasma. J Chromatogr. 1990 Nov 16; 532(2):442-4. PMID: 1964692.
      View in: PubMed
    85. Avramis VI, Champagne J, Sato J, Krailo M, Ettinger LJ, Poplack DG, Finkelstein J, Reaman G, Hammond GD, Holcenberg JS. Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients. Cancer Res. 1990 Nov 15; 50(22):7226-31. PMID: 1699658.
      View in: PubMed
    86. Adamson PC, Poplack DG, Balis FM. Pharmacology and drug resistance in childhood lymphoblastic leukemia. Hematol Oncol Clin North Am. 1990 Oct; 4(5):871-94. PMID: 2262483.
      View in: PubMed
    87. McCully CL, Balis FM, Bacher J, Phillips J, Poplack DG. A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid. Lab Anim Sci. 1990 Sep; 40(5):520-5. PMID: 2170754.
      View in: PubMed
    88. Adamson PC, Balis FM, Miser J, Wells RJ, Bleyer WA, Williams TE, Gillespie A, Penta JS, Clendeninn NJ, Poplack DG. Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule. Cancer Res. 1990 Aug 1; 50(15):4464-7. PMID: 2369724.
      View in: PubMed
    89. Walsh TJ, Lester-McCully C, Rinaldi MG, Wallace JE, Balis FM, Lee JW, Pizzo PA, Poplack DG. Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates. Antimicrob Agents Chemother. 1990 Jun; 34(6):1281-4. PMID: 2393291; PMCID: PMC171803.
    90. Balis FM, Gillespie A, Belasco J, Reaman GH, Ettinger LJ, Murphy RF, Doherty K, Jeffries S, Horowitz ME, Poplack DG. Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas. Invest New Drugs. 1990 May; 8(2):181-2. PMID: 2384304.
      View in: PubMed
    91. Carpen ME, Poplack DG, Pizzo PA, Balis FM. High-performance liquid chromatographic method for analysis of 2',3'-dideoxyinosine in human body fluids. J Chromatogr. 1990 Mar 16; 526(1):69-75. PMID: 2111332.
      View in: PubMed
    92. Felix CA, Poplack DG, Reaman GH, Steinberg SM, Cole DE, Taylor BJ, Begley CG, Kirsch IR. Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood. J Clin Oncol. 1990 Mar; 8(3):431-42. PMID: 2307988.
      View in: PubMed
    93. Perek D, Commers JR, Poplack DG, Pizzo PA. [Infectious complications from intraventricular route of administration in cancer patients]. Probl Med Wieku Rozwoj. 1990; 16:45-53. PMID: 2152412.
      View in: PubMed
    94. Brouwers P, Poplack D. Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits. Am J Pediatr Hematol Oncol. 1990; 12(2):174-81. PMID: 2116096.
      View in: PubMed
    95. Adamson PC, Zimm S, Ragab AH, Steinberg SM, Balis F, Kamen BA, Vietti TJ, Gillespie A, Poplack DG. A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors. Cancer Chemother Pharmacol. 1990; 26(5):343-4. PMID: 2208575.
      View in: PubMed
    96. Heideman RL, Gillespie A, Ford H, Reaman GH, Balis FM, Tan C, Sato J, Ettinger LJ, Packer RJ, Poplack DG. Phase I trial and pharmacokinetic evaluation of fazarabine in children. Cancer Res. 1989 Sep 15; 49(18):5213-6. PMID: 2475244.
      View in: PubMed
    97. Rothenberg ML, Mickley LA, Cole DE, Balis FM, Tsuruo T, Poplack DG, Fojo AT. Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood. 1989 Sep; 74(4):1388-95. PMID: 2765667.
      View in: PubMed
    98. Balis FM, McCully C, Gough L, Pizzo PA, Poplack DG. Pharmacokinetics of subcutaneous azidothymidine in rhesus monkeys. Antimicrob Agents Chemother. 1989 Jun; 33(6):810-2. PMID: 2764527; PMCID: PMC284235.
    99. Rosolen A, Nakanishi M, Poplack DG, Cole D, Quinones R, Reaman G, Trepel JB, Cotelingam JD, Sausville EA, Marti GE, et al. Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies. Blood. 1989 May 15; 73(7):1968-72. PMID: 2653467.
      View in: PubMed
    100. Balis FM, Pizzo PA, Eddy J, Wilfert C, McKinney R, Scott G, Murphy RF, Jarosinski PF, Falloon J, Poplack DG. Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection. J Pediatr. 1989 May; 114(5):880-4. PMID: 2715903.
      View in: PubMed
    101. Moscow JA, Fairchild CR, Madden MJ, Ransom DT, Wieand HS, O'Brien EE, Poplack DG, Cossman J, Myers CE, Cowan KH. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989 Mar 15; 49(6):1422-8. PMID: 2466554.
      View in: PubMed
    102. Balis FM, Pizzo PA, Murphy RF, Eddy J, Jarosinski PF, Falloon J, Broder S, Poplack DG. The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann Intern Med. 1989 Feb 15; 110(4):279-85. PMID: 2643914.
      View in: PubMed
    103. Balis FM, Poplack DG. Central nervous system pharmacology of antileukemic drugs. Am J Pediatr Hematol Oncol. 1989; 11(1):74-86. PMID: 2496615.
      View in: PubMed
    104. Hertler AA, Schlossman DM, Borowitz MJ, Poplack DG, Frankel AE. An immunotoxin for the treatment of T-acute lymphoblastic leukemic meningitis: studies in rhesus monkeys. Cancer Immunol Immunother. 1989; 28(1):59-66. PMID: 2783301.
      View in: PubMed
    105. Balis FM, Jeffries SL, Lange B, Murphy RF, Doherty KM, Arndt CA, Luery N, Poplack DG. Chronopharmacokinetics of oral methotrexate and 6-mercaptopurine: is there diurnal variation in the disposition of antileukemic therapy? Am J Pediatr Hematol Oncol. 1989; 11(3):324-6. PMID: 2782561.
      View in: PubMed
    106. Balis FM, Mirro J, Reaman GH, Evans WE, McCully C, Doherty KM, Murphy RF, Jeffries S, Poplack DG. Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol. 1988 Dec; 6(12):1882-6. PMID: 3199171.
      View in: PubMed
    107. Hockett RD, de Villartay JP, Pollock K, Poplack DG, Cohen DI, Korsmeyer SJ. Human T-cell antigen receptor (TCR) delta-chain locus and elements responsible for its deletion are within the TCR alpha-chain locus. Proc Natl Acad Sci U S A. 1988 Dec; 85(24):9694-8. PMID: 2974161; PMCID: PMC282840.
    108. Poplack DG, Browers P. Late CNS sequelae in long term survivors of childhood leukemia. An Esp Pediatr. 1988 Oct; 29 Suppl 34:19-26. PMID: 3214030.
      View in: PubMed
    109. Ramu N, Ramu A, Cole DE, Balis FM, Poplack DG, Pollard HB. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. Isr J Med Sci. 1988 Sep-Oct; 24(9-10):477-82. PMID: 2974448.
      View in: PubMed
    110. Colamonici OR, Rosolen A, Cole D, Kirsch I, Felix C, Poplack DG, Neckers LM. Stimulation of the beta-subunit of the IL-2 receptor induces MHC-unrestricted cytotoxicity in T acute lymphoblastic leukemia cells and normal thymocytes. J Immunol. 1988 Aug 15; 141(4):1202-5. PMID: 3135323.
      View in: PubMed
    111. Heideman RL, Balis FM, McCully C, Poplack DG. Preclinical pharmacology of arabinosyl-5-azacytidine in nonhuman primates. Cancer Res. 1988 Aug 1; 48(15):4294-8. PMID: 2455594.
      View in: PubMed
    112. Poplack DG, Reaman G. Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am. 1988 Aug; 35(4):903-32. PMID: 3138626.
      View in: PubMed
    113. Jarosinski PF, Moscow JA, Alexander MS, Lesko LJ, Balis FM, Poplack DG. Altered phenytoin clearance during intensive chemotherapy for acute lymphoblastic leukemia. J Pediatr. 1988 Jun; 112(6):996-9. PMID: 3163735.
      View in: PubMed
    114. Arndt CA, Balis FM, McCully CL, Jeffries SL, Doherty K, Murphy R, Poplack DG. Bioavailability of low-dose vs high-dose 6-mercaptopurine. Clin Pharmacol Ther. 1988 May; 43(5):588-91. PMID: 3365920.
      View in: PubMed
    115. Collins JM, Klecker RW, Kelley JA, Roth JS, McCully CL, Balis FM, Poplack DG. Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid. J Pharmacol Exp Ther. 1988 May; 245(2):466-70. PMID: 3367302.
      View in: PubMed
    116. Heideman RL, Kelley JA, Packer RJ, Reaman GH, Roth JS, Balis F, Ettinger LJ, Doherty KM, Jeffries SL, Poplack DG. A pediatric phase I and pharmacokinetic study of spirohydantoin mustard. Cancer Res. 1988 Apr 15; 48(8):2292-5. PMID: 3349492.
      View in: PubMed
    117. Arndt CA, Balis FM, McCully CL, Colvin OM, Poplack DG. Cerebrospinal fluid penetration of active metabolites of cyclophosphamide and ifosfamide in rhesus monkeys. Cancer Res. 1988 Apr 15; 48(8):2113-5. PMID: 3349482.
      View in: PubMed
    118. Rogers P, Allegra CJ, Murphy RF, Drake JC, Masur H, Poplack DG, Chabner BA, Parrillo JE, Lane HC, Balis FM. Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1988 Mar; 32(3):324-6. PMID: 2966610; PMCID: PMC172168.
    119. Colamonici OR, Quinones R, Rosolen A, Trepel JB, Sausville E, Phares JC, Gress R, Poplack D, Weber J, Schechter GP, et al. The beta subunit of the interleukin-2 receptor mediates interleukin-2 induction of anti-CD3 redirected cytotoxic capability in large granular lymphocytes. Blood. 1988 Mar; 71(3):825-8. PMID: 3125866.
      View in: PubMed
    120. Arndt CA, Walsh TJ, McCully CL, Balis FM, Pizzo PA, Poplack DG. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J Infect Dis. 1988 Jan; 157(1):178-80. PMID: 2826606.
      View in: PubMed
    121. Murphy RF, Balis FM, Poplack DG. Stability of 5-fluorouracil in whole blood and plasma. Clin Chem. 1987 Dec; 33(12):2299-300. PMID: 3484334.
      View in: PubMed
    122. Arndt CA, Colvin OM, Balis FM, Lester CM, Johnson G, Poplack DG. Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeys. Cancer Res. 1987 Nov 15; 47(22):5932-4. PMID: 3664493.
      View in: PubMed
    123. Kelley JA, Litterst CL, Roth JS, Vistica DT, Poplack DG, Cooney DA, Nadkarni M, Balis FM, Broder S, Johns DG. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. Drug Metab Dispos. 1987 Sep-Oct; 15(5):595-601. PMID: 2891473.
      View in: PubMed
    124. Greene RF, Miser AW, Lester CM, Balis FM, Poplack DG. Cerebrospinal fluid and plasma pharmacokinetics of morphine infusions in pediatric cancer patients and rhesus monkeys. Pain. 1987 Sep; 30(3):339-48. PMID: 3670879.
      View in: PubMed
    125. Felix CA, Wright JJ, Poplack DG, Reaman GH, Cole D, Goldman P, Korsmeyer SJ. T cell receptor alpha-, beta-, and gamma-genes in T cell and pre-B cell acute lymphoblastic leukemia. J Clin Invest. 1987 Aug; 80(2):545-56. PMID: 3497178; PMCID: PMC442268.
    126. Wright JJ, Poplack DG, Bakhshi A, Reaman G, Cole D, Jensen JP, Korsmeyer SJ. Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia. J Clin Oncol. 1987 May; 5(5):735-41. PMID: 3494818.
      View in: PubMed
    127. Balis FM, Holcenberg JS, Zimm S, Tubergen D, Collins JM, Murphy RF, Gilchrist GS, Hammond D, Poplack DG. The effect of methotrexate on the bioavailability of oral 6-mercaptopurine. Clin Pharmacol Ther. 1987 Apr; 41(4):384-7. PMID: 3470165.
      View in: PubMed
    128. Balis FM, Lester CM, Chrousos GP, Heideman RL, Poplack DG. Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. J Clin Oncol. 1987 Feb; 5(2):202-7. PMID: 3806166.
      View in: PubMed
    129. Browne MJ, Dinndorf PA, Perek D, Commers J, Bleyer WA, Poplack DG, Pizzo PA. Infectious complications of intraventricular reservoirs in cancer patients. Pediatr Infect Dis J. 1987 Feb; 6(2):182-9. PMID: 3562137.
      View in: PubMed
    130. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987 Jan; 84(1):265-9. PMID: 2432605; PMCID: PMC304184.
    131. Winick NJ, Kamen BA, Balis FM, Holcenberg J, Lester CM, Poplack DG. Folate and methotrexate polyglutamate tissue levels in rhesus monkeys following chronic low-dose methotrexate. Cancer Drug Deliv. 1987; 4(1):25-31. PMID: 2440550.
      View in: PubMed
    132. Weber BL, Tanyer G, Poplack DG, Reaman GH, Feusner JH, Miser JS, Bleyer WA. Transient acute hepatotoxicity of high-dose methotrexate therapy during childhood. NCI Monogr. 1987; (5):207-12. PMID: 3481038.
      View in: PubMed
    133. Zimm S, Johnson GE, Poplack DG. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine. Cancer Res. 1986 Dec; 46(12 Pt 1):6286-9. PMID: 3465436.
      View in: PubMed
    134. Strong JM, Collins JM, Lester C, Poplack DG. Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res. 1986 Dec; 46(12 Pt 1):6101-4. PMID: 3096555.
      View in: PubMed
    135. Ratner L, Peylan-Ramu N, Wesley R, Poplack DG. Adverse prognostic influence of hepatitis B virus infection in acute lymphoblastic leukemia. Cancer. 1986 Sep 1; 58(5):1096-100. PMID: 3460683.
      View in: PubMed
    136. Poplack DG, Balis FM, Zimm S. The pharmacology of orally administered chemotherapy. A reappraisal. Cancer. 1986 Jul 15; 58(2 Suppl):473-80. PMID: 3459570.
      View in: PubMed
    137. Zimm S, Reaman G, Murphy RF, Poplack DG. Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia. Cancer Res. 1986 Mar; 46(3):1495-8. PMID: 2417705.
      View in: PubMed
    138. Mastrangelo R, Poplack D, Bleyer A, Riccardi R, Sather H, D'Angio G. Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol. 1986; 14(3):191-4. PMID: 3528788.
      View in: PubMed
    139. Riccardi R, Balis FM, Ferrara P, Lasorella A, Poplack DG, Mastrangelo R. Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1986; 3(4):319-24. PMID: 3153245.
      View in: PubMed
    140. Heideman RL, Balis FM, Zimm S, Lester CM, Poplack DG. The effect of amitriptyline on the central nervous system penetration of methotrexate. Cancer Drug Deliv. 1986; 3(4):219-22. PMID: 3567842.
      View in: PubMed
    141. Balis FM, Murphy RF, Lester CM, Poplack DG. The influence of route of administration on the hepatic uptake of methotrexate. Cancer Drug Deliv. 1986; 3(4):239-42. PMID: 3567844.
      View in: PubMed
    142. Balis FM, Lester CM, Poplack DG. Pharmacokinetics of trimetrexate (NSC 352122) in monkeys. Cancer Res. 1986 Jan; 46(1):169-74. PMID: 2933145.
      View in: PubMed
    143. Zimm S, Johnson GE, Chabner BA, Poplack DG. Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines. Cancer Res. 1985 Sep; 45(9):4156-61. PMID: 2411397.
      View in: PubMed
    144. Blatt J, Sherins RJ, Niebrugge D, Bleyer WA, Poplack DG. Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia. J Clin Oncol. 1985 Sep; 3(9):1227-31. PMID: 3928829.
      View in: PubMed
    145. Nabors MW, Narayan RK, Poplack DG. Intracranial and otological presentation of acute lymphocytic leukemia. Neurosurgery. 1985 Aug; 17(2):309-12. PMID: 3861958.
      View in: PubMed
    146. Srinivasan U, Glaubiger D, Levine AS, Magrath IT, Pizzo PA, Poplack DG. Very high dose cyclophosphamide with imidazole carboximide and vincristine sulfate in the treatment of stage IV neuroblastoma. Am J Clin Oncol. 1985 Jun; 8(3):210-4. PMID: 4050739.
      View in: PubMed
    147. Poplack DG. Acute lymphoblastic leukemia in childhood. Pediatr Clin North Am. 1985 Jun; 32(3):669-97. PMID: 3889802.
      View in: PubMed
    148. Bleyer WA, Poplack DG. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol. 1985 Jun; 12(2):131-48. PMID: 3892694.
      View in: PubMed
    149. Grygiel JJ, Balis FM, Collins JM, Lester CM, Poplack DG. Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys. Cancer Res. 1985 May; 45(5):2037-9. PMID: 3986760.
      View in: PubMed
    150. Brouwers P, Riccardi R, Fedio P, Poplack DG. Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities. J Pediatr. 1985 May; 106(5):723-8. PMID: 3858492.
      View in: PubMed
    151. Balis FM, Savitch JL, Bleyer WA, Reaman GH, Poplack DG. Remission induction of meningeal leukemia with high-dose intravenous methotrexate. J Clin Oncol. 1985 Apr; 3(4):485-9. PMID: 3856631.
      View in: PubMed
    152. Covell DG, Narang PK, Poplack DG. Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fluid. Am J Physiol. 1985 Feb; 248(2 Pt 2):R147-56. PMID: 4038588.
      View in: PubMed
    153. Jolivet J, Cole DE, Holcenberg JS, Poplack DG. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. Cancer Res. 1985 Jan; 45(1):217-20. PMID: 2578094.
      View in: PubMed
    154. Oldfield EH, Schulte HM, Chrousos GP, Rock JP, Kornblith PL, O'Neill DL, Poplack DG, Gold PW, Cutler GB, Loriaux L. Active clearance of corticotropin-releasing factor from the cerebrospinal fluid. Neuroendocrinology. 1985 Jan; 40(1):84-7. PMID: 3871512.
      View in: PubMed
    155. Collins JM, Riccardi R, Trown P, O'Neill D, Poplack DG. Plasma and cerebrospinal fluid pharmacokinetics of recombinant interferon alpha A in monkeys: comparison of intravenous, intramuscular, and intraventricular delivery. Cancer Drug Deliv. 1985; 2(4):247-53. PMID: 4063949.
      View in: PubMed
    156. Riccardi R, Brouwers P, Di Chiro G, Poplack DG. Abnormal computed tomography brain scans in children with acute lymphoblastic leukemia: serial long-term follow-up. J Clin Oncol. 1985 Jan; 3(1):12-8. PMID: 3855309.
      View in: PubMed
    157. Morse M, Savitch J, Balis F, Miser J, Feusner J, Reaman G, Poplack D, Bleyer A. Altered central nervous system pharmacology of methotrexate in childhood leukemia: another sign of meningeal relapse. J Clin Oncol. 1985 Jan; 3(1):19-24. PMID: 3855310.
      View in: PubMed
    158. Bates SE, Raphaelson MI, Price RA, McKeever P, Cohen S, Poplack DG. Ascending myelopathy after chemotherapy for central nervous system acute lymphoblastic leukemia: correlation with cerebrospinal fluid myelin basic protein. Med Pediatr Oncol. 1985; 13(1):4-8. PMID: 2578602.
      View in: PubMed
    159. Zimm S, Grygiel JJ, Strong JM, Monks TJ, Poplack DG. Identification of 6-mercaptopurine riboside in patients receiving 6-mercaptopurine as a prolonged intravenous infusion. Biochem Pharmacol. 1984 Dec 15; 33(24):4089-92. PMID: 6594999.
      View in: PubMed
    160. Kerr IG, Zimm S, Collins JM, O'Neill D, Poplack DG. Effect of intravenous dose and schedule on cerebrospinal fluid pharmacokinetics of 5-fluorouracil in the monkey. Cancer Res. 1984 Nov; 44(11):4929-32. PMID: 6488155.
      View in: PubMed
    161. Sariban E, Oliver C, Corash L, Cossman J, Whang-Peng J, Jaffe ES, Gralnick HR, Poplack DG. Acute megakaryoblastic leukemia in childhood. Cancer. 1984 Oct 1; 54(7):1423-8. PMID: 6540620.
      View in: PubMed
    162. Poplack DG. Massive intrathecal overdose: "check the label twice!". N Engl J Med. 1984 Aug 9; 311(6):400-2. PMID: 6547509.
      View in: PubMed
    163. Brouwers P, Riccardi R, Poplack D, Fedio P. Attentional deficits in long-term survivors of childhood acute lymphoblastic leukemia (ALL). J Clin Neuropsychol. 1984 Aug; 6(3):325-36. PMID: 6590573.
      View in: PubMed
    164. Zimm S, Collins JM, Miser J, Chatterji D, Poplack DG. Cytosine arabinoside cerebrospinal fluid kinetics. Clin Pharmacol Ther. 1984 Jun; 35(6):826-30. PMID: 6587957.
      View in: PubMed
    165. Zimm S, Collins JM, Curt GA, O'Neill D, Poplack DG. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone. Cancer Res. 1984 Apr; 44(4):1698-701. PMID: 6704975.
      View in: PubMed
    166. Gangji D, Ross WE, Bleyer WA, Poplack DG, Glaubiger DL. Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells. Cancer Treat Rep. 1984 Mar; 68(3):521-5. PMID: 6704981.
      View in: PubMed
    167. Blatt J, Bercu BB, Gillin JC, Mendelson WB, Poplack DG. Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr. 1984 Feb; 104(2):182-6. PMID: 6582247.
      View in: PubMed
    168. Gormley P, Riccardi R, O'Neill D, Poplack D. Intrathecally administered m-AMSA in the rhesus monkey. Cancer Drug Deliv. 1984; 1(2):101-7. PMID: 6549572.
      View in: PubMed
    169. Zimm S, Collins JM, O'Neill D, Chabner BA, Poplack DG. Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin Pharmacol Ther. 1983 Dec; 34(6):810-7. PMID: 6580097.
      View in: PubMed
    170. Mann DL, Haynes BF, Thomas C, Cole D, Fauci AS, Poplack DG. Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies. J Natl Cancer Inst. 1983 Jul; 71(1):11-7. PMID: 6602900.
      View in: PubMed
    171. Zimm S, Collins JM, Riccardi R, O'Neill D, Narang PK, Chabner B, Poplack DG. Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered? N Engl J Med. 1983 Apr 28; 308(17):1005-9. PMID: 6572786.
      View in: PubMed
    172. Korsmeyer SJ, Arnold A, Bakhshi A, Ravetch JV, Siebenlist U, Hieter PA, Sharrow SO, LeBien TW, Kersey JH, Poplack DG, Leder P, Waldmann TA. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest. 1983 Feb; 71(2):301-13. PMID: 6401769; PMCID: PMC436868.
    173. Narang PK, Chatterji DC, O'Neill D, Poplack DG. Pharmacokinetics of 6-mercaptopurine (6MP) in the monkey. I. Disposition from plasma and cerebrospinal fluid following iv bolus. Drug Metab Dispos. 1983 Jan-Feb; 11(1):5-9. PMID: 6132796.
      View in: PubMed
    174. Ladisch S, Poplack DG, Blaese RM. Inhibition of human lymphoproliferation by intravenous lipid emulsion. Clin Immunol Immunopathol. 1982 Nov; 25(2):196-202. PMID: 7166013.
      View in: PubMed
    175. Blatt J, Bunn PA, Carney DD, Reaman G, Soprey P, Poplack DG. Purine pathway enzymes in the circulating malignant cells of patients with cutaneous T-cell lymphoma. Br J Haematol. 1982 Sep; 52(1):97-104. PMID: 6288063.
      View in: PubMed
    176. Trigg ME, Wesley RA, Holiman BJ, Cole DE, Poplack DG. A rapid, single step technique for determination of B and T cell surface markers in malignant lymphoid cells. Exp Hematol. 1982 Sep; 10(8):668-74. PMID: 6982827.
      View in: PubMed
    177. Agarwal RP, Blatt J, Miser J, Sallan S, Lipton JM, Reaman GH, Holcenberg J, Poplack DG. Clinical pharmacology of 9-beta-D-arabinofuranosyladenine in combination with 2'-deoxycoformycin. Cancer Res. 1982 Sep; 42(9):3884-6. PMID: 6980706.
      View in: PubMed
    178. Blatt J, Spiegel RJ, Papadopoulos NM, Lazarou SA, Magrath IT, Poplack DG. Lactate dehydrogenase isoenzymes in normal and malignant human lymphoid cells. Blood. 1982 Aug; 60(2):491-4. PMID: 6980034.
      View in: PubMed
    179. Srinivasan U, Reaman GH, Poplack DG, Glaubiger DL, LeVine AS. Phase II study of 5-azacytidine in sarcomas of bone. Am J Clin Oncol. 1982 Aug; 5(4):411-5. PMID: 6180626.
      View in: PubMed
    180. Trigg ME, Poplack DG. Transplantation of leukemic bone marrow treated with cytotoxic antileukemic antibodies and complement. Science. 1982 Jul 16; 217(4556):259-61. PMID: 7046048.
      View in: PubMed
    181. McGovren JP, Stewart JC, Elfring GL, Smith RB, Soares N, Wood JH, Poplack DG, Von Hoff DD. Plasma and cerebrospinal fluid pharmacokinetics of acivicin in Ommaya reservoir-bearing rhesus monkeys. Cancer Treat Rep. 1982 Jun; 66(6):1333-41. PMID: 7083237.
      View in: PubMed
    182. Chrousos GP, Poplack D, Brown T, O'Neill D, Schwade J, Bercu BB. Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics. J Clin Endocrinol Metab. 1982 Jun; 54(6):1135-9. PMID: 7042731.
      View in: PubMed
    183. Riccardi R, Chabner B, Glaubiger DL, Wood J, Poplack DG. Influence of tetrahydrouridine on the pharmacokinetics of intrathecally administered 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1982 May; 42(5):1736-9. PMID: 6896013.
      View in: PubMed
    184. Riccardi R, Vigersky RA, Barnes S, Bleyer WA, Poplack DG. Methotrexate levels in the interstitial space and seminiferous tubule of rat testis. Cancer Res. 1982 May; 42(5):1617-9. PMID: 7066883.
      View in: PubMed
    185. Blatt J, Venner PM, Riccardi R, Cohen LF, Gangji D, Glazer RI, Poplack DG. Cerebrospinal fluid levels of 2'-deoxycoformycin after systemic administration in monkeys. J Natl Cancer Inst. 1982 Mar; 68(3):391-3. PMID: 6977672.
      View in: PubMed
    186. Wortmann RL, Holcenberg J, Poplack DG. Relationship of 5'-nucleotidase activity and antileukemic effect in 2'-deoxycoformycin therapy. Cancer Treat Rep. 1982 Feb; 66(2):387-90. PMID: 6275991.
      View in: PubMed
    187. Poplack DG, Blatt J, Reaman G. Purine pathway enzyme abnormalities in acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 2):4821-23. PMID: 6271395.
      View in: PubMed
    188. Korsmeyer SJ, Hieter PA, Ravetch JV, Poplack DG, Waldmann TA, Leder P. Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A. 1981 Nov; 78(11):7096-100. PMID: 6273911; PMCID: PMC349202.
    189. Riccardi R, Holcenberg JS, Glaubiger DL, Wood JH, Poplack DG. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res. 1981 Nov; 41(11 Pt 1):4554-8. PMID: 6895481.
      View in: PubMed
    190. Venner PM, Glazer RI, Blatt J, Sallan S, Rivera G, Holcenberg JS, Lipton J, Murphy SB, Poplack DG. Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 1):4508-11. PMID: 6975654.
      View in: PubMed
    191. Poplack DG, Sallan SE, Rivera G, Holcenberg J, Murphy SB, Blatt J, Lipton JM, Venner P, Glaubiger DL, Ungerleider R, Johns D. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. Cancer Res. 1981 Sep; 41(9 Pt 1):3343-6. PMID: 6973390.
      View in: PubMed
    192. Reaman GH, Blatt J, Poplack DG. Lymphoblast purine pathway enzymes in B-cell acute lymphoblastic leukemia. Blood. 1981 Aug; 58(2):330-2. PMID: 6264997.
      View in: PubMed
    193. Moss HA, Nannis ED, Poplack DG. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am J Med. 1981 Jul; 71(1):47-52. PMID: 6941699.
      View in: PubMed
    194. Broder S, Uchiyama T, Muul LM, Goldman C, Sharrow S, Poplack DG, Waldmann TA. Activation of leukemic pro-suppressor cells to become suppressor-effector cells. Influence of cooperating normal T cells. N Engl J Med. 1981 Jun 4; 304(23):1382-7. PMID: 6453293.
      View in: PubMed
    195. Blatt J, Poplack DG, Sherins RJ. Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med. 1981 May 7; 304(19):1121-4. PMID: 6783900.
      View in: PubMed
    196. Gormley PE, Gangji D, Wood JH, Poplack DG. Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II). Cancer Chemother Pharmacol. 1981; 5(4):257-60. PMID: 7196299.
      View in: PubMed
    197. Poplack DG, Reaman GH, Wesley R. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen. Cancer Treat Rep. 1981; 65 Suppl 4:93-6. PMID: 6955015.
      View in: PubMed
    198. Chrousos GP, Poplack D, Kostolich M, Wiede C, Oliff A, Brown T, Bercu BB. Hypothalamic-adenohypophyseal function in male rhesus monkeys. A primate model. J Med Primatol. 1981; 10(2-3):61-71. PMID: 6802979.
      View in: PubMed
    199. Gangji D, Poplack DG, Schwade J, Wood JH, Strong JM. Misonidazole blood and cerebrospinal fluid kinetics in monkeys following intravenous and intrathecal administration. Eur J Cancer. 1981 Jan; 17(1):29-34. PMID: 6894901.
      View in: PubMed
    200. Thomas WJ, North RB, Poplack DG, Slease RB, Duval-Arnould B. Chronic myelomonocytic leukemia in childhood. Am J Hematol. 1981; 10(2):181-94. PMID: 6940441.
      View in: PubMed
    201. Gormley PE, Wood JH, Poplack DG. Ability of a new antitumor agent, AZQ, to penetrate into cerebrospinal fluid. Pharmacology. 1981; 22(3):196-8. PMID: 7208602.
      View in: PubMed
    202. Blatt J, Mulvihill JJ, Ziegler JL, Young RC, Poplack DG. Pregnancy outcome following cancer chemotherapy. Am J Med. 1980 Dec; 69(6):828-32. PMID: 7446548.
      View in: PubMed
    203. Reaman GH, Poplack DG, Broder S, Pichler WJ. Fc receptors on human T lymphocytes. V: Effects of colchicine and cytochalasin B on Fc receptor expression. J Immunol. 1980 Nov; 125(5):2215-9. PMID: 7000898.
      View in: PubMed
    204. Blatt J, Reaman G, Poplack DG. Current concepts. Biochemical markers in lymphoid malignancy. N Engl J Med. 1980 Oct 16; 303(16):918-22. PMID: 6251368.
      View in: PubMed
    205. Blatt J, Reaman GH, Levin N, Poplack DG. Purine nucleoside phosphorylase activity in acute lymphoblastic leukemia. Blood. 1980 Sep; 56(3):380-2. PMID: 6773605.
      View in: PubMed
    206. Gangji D, Reaman GH, Cohen SR, Bleyer WA, Poplack DG. Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N Engl J Med. 1980 Jul 3; 303(1):19-21. PMID: 6154890.
      View in: PubMed
    207. Bode U, Magrath IT, Bleyer WA, Poplack DG, Glaubiger DL. Active transport of methotrexate from cerebrospinal fluid in humans. Cancer Res. 1980 Jul; 40(7):2184-7. PMID: 7388786.
      View in: PubMed
    208. Reaman GH, Ladisch S, Echelberger C, Poplack DG. Improved treatment results in the management of single and multiple relapses of acute lymphoblastic leukemia. Cancer. 1980 Jun 15; 45(12):3090-4. PMID: 6930318.
      View in: PubMed
    209. Reaman GH, Lum LG, Poplack DG. The detection of Fc-IgA receptors on T and non-T, non-B acute leukemic lymphoblasts. Cell Immunol. 1980 Jun; 52(1):218-22. PMID: 6966979.
      View in: PubMed
    210. von Hoff DD, Soares N, Gormley P, Poplack DG. Pharmacokinetics of ICRF-187 in the cerebrospinal fluid of subhuman primates. Cancer Treat Rep. 1980 Apr-May; 64(4-5):734-6. PMID: 6775806.
      View in: PubMed
    211. Cohen LF, Balow JE, Magrath IT, Poplack DG, Ziegler JL. Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma. Am J Med. 1980 Apr; 68(4):486-91. PMID: 7369230.
      View in: PubMed
    212. Jackson DV, Castle MC, Poplack DG, Bender RA. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates. Cancer Res. 1980 Mar; 40(3):722-4. PMID: 7471091.
      View in: PubMed
    213. Spiegel RJ, Echelberger CK, Poplack DG. Delayed allergic reactions following intramuscular L-asparaginase. Med Pediatr Oncol. 1980; 8(2):123-5. PMID: 6932563.
      View in: PubMed
    214. Blaese RM, Poplack DG, Muchmore AV. The mononuclear phagocyte system: role in expression of immunocompetence in neonatal and adult life. Pediatrics. 1979 Nov; 64(5 Pt 2 Suppl):829-33. PMID: 503700.
      View in: PubMed
    215. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG, Levine AS, Deisseroth AB, Glaubiger DL, Maclowry JD, Magrath IT, Poplack DG, Simon RM. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 1979 Aug; 67(2):194-200. PMID: 380336.
      View in: PubMed
    216. Reaman GH, Pichler WJ, Broder S, Poplack DG. Characterization of lymphoblast Fc receptor expression in acute lymphoblastic leukemia. Blood. 1979 Jul; 54(1):285-91. PMID: 312672.
      View in: PubMed
    217. Ladisch S, Reaman GH, Poplack DG. Bacillus Calmette-Guérin enhancement of colony-stimulating activity and myeloid colony formation following administration of cyclophosphamide. Cancer Res. 1979 Jul; 39(7 Pt 1):2544-6. PMID: 445455.
      View in: PubMed
    218. Reaman GH, Levin N, Muchmore A, Holiman BJ, Poplack DG. Diminished lymphoblast 5'-nucleotidase activity in acute lymphoblastic leukemia with T-cell characteristics. N Engl J Med. 1979 Jun 14; 300(24):1374-7. PMID: 312462.
      View in: PubMed
    219. Spiegel RJ, Vigersky RA, Oliff AI, Echelberger CK, Bruton J, Poplack DG. Adrenal suppression after short-term corticosteroid therapy. Lancet. 1979 Mar 24; 1(8117):630-3. PMID: 85870.
      View in: PubMed
    220. Nelson DL, Poplack DG, Holiman BJ, Henkart PA. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity. Clin Exp Immunol. 1979 Mar; 35(3):447-53. PMID: 455783; PMCID: PMC1537609.
    221. Poplack DG, Bleyer WA, Pizzo PA. Experimental approaches to the treatment of CNS leukemia. Am J Pediatr Hematol Oncol. 1979; 1(2):141-9. PMID: 120681.
      View in: PubMed
    222. Bleyer WA, Poplack DG. Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoir. Med Pediatr Oncol. 1979; 6(3):207-13. PMID: 288969.
      View in: PubMed
    223. Oliff A, Bode U, Bercu BB, Di Chiro G, Graves V, Poplack DG. Hypothalamic-pituitary dysfunction following CNS prophylaxis in acute lymphocytic leukemia: correlation with CT scan abnormalities. Med Pediatr Oncol. 1979; 7(2):141-51. PMID: 291772.
      View in: PubMed
    224. Pizzo PA, Poplack DG, Bleyer WA. Neurotoxicities of current leukemia therapy. Am J Pediatr Hematol Oncol. 1979; 1(2):127-40. PMID: 396797.
      View in: PubMed
    225. Oliff A, Bleyer WA, Poplack DG. Methotrexate-induced oral mucositis and salivary methotrexate concentrations. Cancer Chemother Pharmacol. 1979; 2(3):225-6. PMID: 313282.
      View in: PubMed
    226. Ziegler JL, Magrath IT, Deisseroth AB, Glaubiger DL, Kent HC, Pizzo PA, Poplack DG, Levine AS. Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep. 1978 Dec; 62(12):2031-4. PMID: 751712.
      View in: PubMed
    227. Tosato G, Whang-Peng J, Levine AS, Poplack DG. Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. Blood. 1978 Nov; 52(5):1033-6. PMID: 279358.
      View in: PubMed
    228. Smyth JF, Poplack DG, Holiman BJ, Leventhal BG, Yarbro G. Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. J Clin Invest. 1978 Sep; 62(3):710-2. PMID: 308513; PMCID: PMC371818.
    229. Oliff A, Ramu NP, Poplack D. Leukemic relapse 5 1/2 years after allogeneic bone marrow transplantation. Blood. 1978 Aug; 52(2):281-4. PMID: 352442.
      View in: PubMed
    230. Oliff A, Bleyer WA, Poplack DG. Acute encephalopathy after initiation of cranial irradiation for meningeal leukaemia. Lancet. 1978 Jul 1; 2(8079):13-5. PMID: 78211.
      View in: PubMed
    231. Bleyer WA, Pizzo PA, Spence AM, Platt WD, Benjamin DR, Kolins CJ, Poplack DG. The Ommaya reservoir: newly recognized complications and recommendations for insertion and use. Cancer. 1978 Jun; 41(6):2431-7. PMID: 274993.
      View in: PubMed
    232. Bleyer WA, Poplack DG, Simon RM. "Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood. 1978 May; 51(5):835-42. PMID: 638249.
      View in: PubMed
    233. Reaman GH, Poplack DG, Pizzo PA. Late soft tissue recurrence of acute lymphoblastic leukemia in a site of antecedent trauma. J Pediatr. 1978 May; 92(5):849-50. PMID: 273677.
      View in: PubMed
    234. Peylan-Ramu N, Poplack DG, Pizzo PA, Adornato BT, Di Chiro G. Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med. 1978 Apr 13; 298(15):815-8. PMID: 273143.
      View in: PubMed
    235. Ladisch S, Poplack DG, Bull JM. Acceleration of myeloid recovery from cyclophosphamide-induced leukopenia by pretreatment with Bacillus Calmette-Guérin. Cancer Res. 1978 Apr; 38(4):1049-51. PMID: 639036.
      View in: PubMed
    236. Ladisch S, Poplack DG, Holiman B, Blaese RM. Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet. 1978 Mar 18; 1(8064):581-3. PMID: 76124.
      View in: PubMed
    237. Appelbaum FR, Deisseroth AB, Graw RG, Herzig GP, Levine AS, Magrath IT, Pizzo PA, Poplack DG, Ziegler JL. Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer. 1978 Mar; 41(3):1059-63. PMID: 638947.
      View in: PubMed
    238. Levine AS, Appelbaum FR, Graw RG, Magrath IT, Pizzo PA, Poplack DG, Ziegler JL. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma. Cancer Treat Rep. 1978 Feb; 62(2):247-50. PMID: 346213.
      View in: PubMed
    239. Broder S, Poplack D, Whang-Peng J, Durm M, Goldman C, Muul L, Waldmann TA. Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. N Engl J Med. 1978 Jan 12; 298(2):66-72. PMID: 304175.
      View in: PubMed
    240. Oliff A, Poplack D. Characteristics of long-term survivors in AML. Med Pediatr Oncol. 1978; 5(1):219-23. PMID: 284169.
      View in: PubMed
    241. Fusner JE, Pizzo PA, Poplack DG, Freeman C. Meningeal relapse of orbital rhabdomyosarcoma. Med Pediatr Oncol. 1978; 4(3):247-51. PMID: 683128.
      View in: PubMed
    242. Wood JH, Poplack DG, Flor WJ, Gunby EN, Ommaya AK. Chronic ventricular cerebrospinal fluid sampling, drug injections, and pressure monitoring using subcutaneous reservoirs in monkeys. Neurosurgery. 1977 Sep-Oct; 1(2):132-5. PMID: 98727.
      View in: PubMed
    243. Fusner JE, Poplack DG, Pizzo PA, Di Chiro G. Leukoencephalopathy following chemotherapy for rhabdomyosarcoma: reversibility of cerebral changes demonstrated by computed tomography. J Pediatr. 1977 Jul; 91(1):77-9. PMID: 874669.
      View in: PubMed
    244. Poplack DG, Bleyer WA, Wood JH, Kostolich M, Savitch JL, Ommaya AK. A primate model for study of methotrexate pharmacokinetics in the central nervous system. Cancer Res. 1977 Jul; 37(7 Pt 1):1982-5. PMID: 405092.
      View in: PubMed
    245. Sher NA, Poplack DG, Blaese RM, Brown TM, Chaparas SD. Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis. J Natl Cancer Inst. 1977 Jun; 58(6):1753-7. PMID: 864753.
      View in: PubMed
    246. Peylan-Ramu N, Poplack DG, Blei CL, Herdt JR, Vermess M, Di Chiro G. Computer assisted tomography in methotrexate encephalopathy. J Comput Assist Tomogr. 1977 Apr; 1(2):216-21. PMID: 615198.
      View in: PubMed
    247. Wood JH, Poplack DG, Bleyer WA, Ommaya AK. Primate model for long-term study of intraventricularly or intrathecally administered drugs and intracranial pressure. Science. 1977 Feb 4; 195(4277):499-501. PMID: 402027.
      View in: PubMed
    248. Margileth DA, Poplack DG, Pizzo PA, Leventhal BG. Blindness during remission in two patients with acute lymphoblastic leukemia: a possible complication of multimodality therapy. Cancer. 1977 Jan; 39(1):58-61. PMID: 264409.
      View in: PubMed
    249. Poplack DG, Bonnard GD, Holiman BJ, Blaese RM. Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood. 1976 Dec; 48(6):809-16. PMID: 1000082.
      View in: PubMed
    250. Gerety RJ, Poplack DG, Hoofnagle JH, Blaese RM, Holland PV, Barker LF. Hepatitis B virus infection in the Wiskott-Aldrich syndrome. J Pediatr. 1976 Apr; 88(4 Pt 1):561-4. PMID: 1255311.
      View in: PubMed
    251. Poplack DG, Sher NA, Chaparas SD, Blaese RM. The effect of Mycobacterium bovis (Bacillus Calmette-Guérin) on macrophage random migration, chemotaxis, and pinocytosis. Cancer Res. 1976 Apr; 36(4):1233-7. PMID: 769964.
      View in: PubMed
    252. Pizzo PA, Bleyer WA, Poplack DG, Leventhal BG. Reversible dementia temporally associated with intraventricular therapy with methotrexate in a child with acute myelogenous leukemia. J Pediatr. 1976 Jan; 88(1):131-3. PMID: 1060745.
      View in: PubMed
    253. Sacks KL, Olweny C, Mann DL, Simon R, Johnson GE, Poplack DG, Leventhal BG. A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia. Cancer Res. 1975 Dec; 35(12):3715-20. PMID: 127655.
      View in: PubMed
    254. Poplack DG, Jacobs SA. Candida arthritis treated with amphotericin B. J Pediatr. 1975 Dec; 87(6 Pt 1):989-90. PMID: 1059760.
      View in: PubMed
    255. Shohet SB, Pitt J, Baehner RL, Poplack DG. Lipid peroxidation in the killing of phagocytized pneumococci. Infect Immun. 1974 Dec; 10(6):1321-8. PMID: 4154921; PMCID: PMC423106.
    256. Poplack DG, Penland WZ, Levine AS. Bacteriological isolation garment. Lancet. 1974 Jun 22; 1(7869):1261-2. PMID: 4134147.
      View in: PubMed
    257. Herzig RH, Poplack DG, Yankee RA. Prolonged granulocytopenia from incompatible platelet transfusions. N Engl J Med. 1974 May 30; 290(22):1220-3. PMID: 4825852.
      View in: PubMed
    POPLACK's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _